Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14580748 | 0.92 | CA12 (0.36) | — | |
| SCHEMBL23349277 | 0.86 | — | — | |
| SCHEMBL12039791 | 0.86 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL20756047 | 0.84 | ALDH1A1 (0.33) | ALDH1A1TSHRMAPK1 | |
| SCHEMBL13412943 | 0.84 | MEN1 (0.40) | TSHR | |
| SCHEMBL20004943 | 0.82 | DNM1 (0.33) | ALDH1A1SIGMAR1 | |
| SCHEMBL12039760 | 0.79 | PIK3CD (0.32) | ALDH1A1TSHRMAPK1MAOB | |
| SCHEMBL29951553 | 0.78 | ADH1B (0.30) | — | |
| SCHEMBL31616903 | 0.78 | TSHR (0.33) | TSHRMAPK1MAOB | |
| SCHEMBL31616907 | 0.78 | TSHR (0.33) | TSHRMAPK1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170158610-A1 | NONIONIC SURFACTANT COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2017-06-08 | — | — | US | disclosed |
| US-9382192-B2 | Nonionic surfactant compositions | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160016886-A1 | NONIONIC SURFACTANT COMPOSITIONS | DOW GLOBAL TECHNOLOGIES LLC | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170158610-A1 | NONIONIC SURFACTANT COMPOSITIONS | SPNS2, SGMS2, SGMS1 | ALDH1A1 4568/4885TSHR 2600/4885MAPK1 4081/4885 |
| US-20160016886-A1 | NONIONIC SURFACTANT COMPOSITIONS | SPNS2, SGMS2, SGMS1 | ALDH1A1 4641/4885TSHR 2643/4885MAPK1 4356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.